RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 39 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,441,537 | +29.0% | 4,785,494 | 0.0% | 2.81% | +30.5% |
| Q2 2023 | $28,253,557 | -1.3% | 4,785,494 | 0.0% | 2.16% | +9.0% |
| Q1 2023 | $28,617,254 | +156.7% | 4,785,494 | 0.0% | 1.98% | +215.5% |
| Q4 2022 | $11,150,201 | -30.5% | 4,785,494 | -0.0% | 0.63% | -21.6% |
| Q3 2022 | $16,036,000 | +26.4% | 4,786,921 | 0.0% | 0.80% | +22.7% |
| Q2 2022 | $12,685,000 | -9.9% | 4,786,921 | 0.0% | 0.65% | +60.6% |
| Q1 2022 | $14,073,000 | -65.6% | 4,786,921 | 0.0% | 0.41% | -50.9% |
| Q4 2021 | $40,928,000 | +14.8% | 4,786,921 | 0.0% | 0.83% | +95.0% |
| Q3 2021 | $35,663,000 | -20.1% | 4,786,921 | 0.0% | 0.42% | -27.1% |
| Q2 2021 | $44,662,000 | – | 4,786,921 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |